The lipid nanoparticles market encompasses the sector dedicated to the development, production, and application of lipid-based nanocarriers for drug delivery and therapeutic purposes. These nanoparticles are pivotal in enhancing the bioavailability and stability of pharmaceuticals, particularly in mRNA vaccines and targeted cancer therapies. The market is driven by advancements in nanotechnology, growing demand for personalized medicine, and the increasing prevalence of chronic diseases, positioning lipid nanoparticles as a cornerstone in modern drug delivery systems.